» Articles » PMID: 15347506

Treatment of Lichen Planopilaris with Mycophenolate Mofetil

Overview
Specialty Dermatology
Date 2004 Sep 7
PMID 15347506
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Mycophenolate mofetil (MMF) is an immunosuppressive drug that has recently been used to treat autoimmune and inflammatory skin diseases. We report the first case of lichen planopilaris (LPP) successfully treated with MMF. The treatment of our patient demonstrates a novel therapeutic option for patients with LPP; MMF treatment may be preferable to azathioprine treatment because MMF has a safer adverse-effect profile. Larger studies must be performed to establish the risk-benefit ratio of various therapeutic dosages of MMF for these patients.

Citing Articles

Comparative Efficacy Study Combination of Oral Methotrexate and Prednisolone versus Oral Methotrexate in Patients with Lichen Planopilaris.

Fatemi F, Esfahanian F, Asilian A, Mohaghegh F, Saber M Dermatol Res Pract. 2022; 2022:3792489.

PMID: 36254319 PMC: 9569223. DOI: 10.1155/2022/3792489.


Therapeutic management of classic lichen planopilaris: a systematic review.

Errichetti E, Figini M, Croatto M, Stinco G Clin Cosmet Investig Dermatol. 2018; 11:91-102.

PMID: 29520159 PMC: 5833781. DOI: 10.2147/CCID.S137870.


Clinical Efficacy and Safety of Methotrexate versus Hydroxychloroquine in Preventing Lichen Planopilaris Progress: A Randomized Clinical Trial.

Fatemi Naeini F, Saber M, Asilian A, Hosseini S Int J Prev Med. 2017; 8:37.

PMID: 28584619 PMC: 5450502. DOI: 10.4103/ijpvm.IJPVM_156_17.


[Frontal fibrosing alopecia with androgenetic pattern. A diagnostic challenge - a therapeutic problem].

Tremezaygues L, Vogt T, Muller C Hautarzt. 2011; 63(5):411-4.

PMID: 21971770 DOI: 10.1007/s00105-011-2242-6.


Alopecia: evaluation and treatment.

Gordon K, Tosti A Clin Cosmet Investig Dermatol. 2011; 4:101-6.

PMID: 21833160 PMC: 3149477. DOI: 10.2147/CCID.S10182.